4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-047640
Chief Financial Officer sold 10,000 shares at $40.00 ($400,000)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-08-17 | Option exercise | +10,000 | $6.32 | $63,200 | 11,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-08-17 | Sale | −10,000 | $40.00 | $400,000 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-08-17 | Option exercise · Stock Option (Right To Buy) | −10,000 | 610,000 | D | ||
| Open-market sales · 10,000 sh · avg $40.00 · $400,000 | |||||||
Loading xslF345X03/doc4.xml…